$1.24 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 127 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 92.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INSM | Buy | INSMED INC | $26,004,000 | +106.2% | 913,700 | +146.8% | 2.10% | +120.1% |
| RCM | Buy | R1 RCM INC | $25,255,000 | -4.2% | 1,135,589 | +6.4% | 2.04% | +2.3% |
| SYNH | New | SYNEOS HEALTH INCcl a | $24,270,000 | – | 271,206 | +100.0% | 1.96% | – |
| AXNX | New | AXONICS INC | $23,376,000 | – | 368,650 | +100.0% | 1.89% | – |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $22,001,000 | -1.4% | 322,599 | +0.3% | 1.78% | +5.2% |
| A | Buy | AGILENT TECHNOLOGIES INC | $21,610,000 | +37.1% | 146,200 | +17.9% | 1.75% | +46.3% |
| OLK | Buy | OLINK HLDG ABsponsored ads | $21,135,000 | +38.1% | 614,025 | +44.4% | 1.71% | +47.4% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $20,822,000 | +4.8% | 470,135 | +5.0% | 1.68% | +11.8% |
| AVAH | New | AVEANNA HEALTHCARE HLDGS INC | $20,509,000 | – | 1,658,000 | +100.0% | 1.66% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $20,161,000 | +15.5% | 2,091,404 | +18.4% | 1.63% | +23.3% |
| CNVY | New | CONVEY HLDG PARENT INC | $19,915,000 | – | 1,750,000 | +100.0% | 1.61% | – |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $19,864,000 | +76.1% | 325,850 | +78.0% | 1.61% | +88.0% |
| AGLY | New | AGILITI INC | $18,116,000 | – | 828,369 | +100.0% | 1.47% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $15,987,000 | +21.9% | 170,725 | +19.8% | 1.29% | +30.1% |
| BHG | New | BRIGHT HEALTH GROUP INC | $15,650,000 | – | 912,000 | +100.0% | 1.27% | – |
| OLMA | Buy | OLEMA PHARMACEUTICALS INC | $13,711,000 | +3103.5% | 490,020 | +3698.6% | 1.11% | +3365.6% |
| NKTX | Buy | NKARTA INC | $13,011,000 | +133.9% | 410,580 | +142.9% | 1.05% | +149.5% |
| INSP | Buy | INSPIRE MED SYS INC | $12,997,000 | +3.8% | 67,250 | +11.2% | 1.05% | +10.9% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $12,851,000 | +4086.0% | 412,150 | +4021.5% | 1.04% | +4421.7% |
| FATE | Buy | FATE THERAPEUTICS INC | $12,758,000 | +8.6% | 147,000 | +3.2% | 1.03% | +15.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $11,533,000 | +31.1% | 28,800 | +21.8% | 0.93% | +39.9% |
| AVTE | New | AEROVATE THERAPEUTICS INC | $11,415,000 | – | 500,000 | +100.0% | 0.92% | – |
| DNAY | New | CODEX DNA INC | $11,359,000 | – | 516,306 | +100.0% | 0.92% | – |
| NPCE | New | NEUROPACE INC | $11,228,000 | – | 471,966 | +100.0% | 0.91% | – |
| ABT | Buy | ABBOTT LABS | $10,891,000 | +14.0% | 93,948 | +17.9% | 0.88% | +21.7% |
| SGEN | Buy | SEAGEN INC | $10,792,000 | +48.3% | 68,356 | +30.4% | 0.87% | +58.2% |
| TALS | New | TALARIS THERAPEUTICS INC | $10,445,000 | – | 711,000 | +100.0% | 0.84% | – |
| MDT | Buy | MEDTRONIC PLC | $9,571,000 | +54.3% | 77,101 | +46.9% | 0.77% | +64.7% |
| NVCR | New | NOVOCURE LTD | $9,272,000 | – | 41,800 | +100.0% | 0.75% | – |
| GH | Buy | GUARDANT HEALTH INC | $8,965,000 | -17.7% | 72,186 | +1.1% | 0.72% | -12.2% |
| CTLT | Buy | CATALENT INC | $8,893,000 | +7.9% | 82,250 | +5.1% | 0.72% | +15.2% |
| CRL | New | CHARLES RIV LABS INTL INC | $8,434,000 | – | 22,800 | +100.0% | 0.68% | – |
| PFE | Buy | PFIZER INC | $7,574,000 | +139.2% | 193,400 | +121.3% | 0.61% | +155.4% |
| TMCI | New | TREACE MED CONCEPTS INC | $7,526,000 | – | 240,765 | +100.0% | 0.61% | – |
| EXAS | Buy | EXACT SCIENCES CORP | $7,272,000 | +0.3% | 58,500 | +6.4% | 0.59% | +7.1% |
| XRAY | New | DENTSPLY SIRONA INC | $6,832,000 | – | 108,000 | +100.0% | 0.55% | – |
| BIIB | Buy | BIOGEN INC | $6,729,000 | +92.7% | 19,432 | +55.7% | 0.54% | +105.3% |
| STAA | New | STAAR SURGICAL CO | $6,558,000 | – | 43,000 | +100.0% | 0.53% | – |
| ICLR | New | ICON PLC | $5,943,000 | – | 28,750 | +100.0% | 0.48% | – |
| MRK | New | MERCK & CO INC | $5,852,000 | – | 75,250 | +100.0% | 0.47% | – |
| THC | New | TENET HEALTHCARE CORP | $5,694,000 | – | 85,000 | +100.0% | 0.46% | – |
| SWAV | New | SHOCKWAVE MED INC | $5,312,000 | – | 28,000 | +100.0% | 0.43% | – |
| DNLI | Buy | DENALI THERAPEUTICS INC | $5,099,000 | +2136.4% | 65,000 | +1525.0% | 0.41% | +2329.4% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $4,959,000 | +24.9% | 115,976 | +12.9% | 0.40% | +33.2% |
| TKNO | New | ALPHA TEKNOVA INC | $3,774,000 | – | 159,060 | +100.0% | 0.30% | – |
| GLUE | New | MONTE ROSA THERAPEUTICS INC | $2,943,000 | – | 129,633 | +100.0% | 0.24% | – |
| LATN | New | UNION ACQUISITION CORP II | $2,175,000 | – | 215,582 | +100.0% | 0.18% | – |
| BGNE | Buy | BEIGENE LTDsponsored adr | $2,059,000 | +2.0% | 6,000 | +3.4% | 0.17% | +9.2% |
| IQV | New | IQVIA HLDGS INC | $727,000 | – | 3,000 | +100.0% | 0.06% | – |
| ALVR | Buy | ALLOVIR INC | $690,000 | +37.5% | 34,950 | +62.9% | 0.06% | +47.4% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $467,000 | +11.5% | 3,550 | +9.2% | 0.04% | +18.8% |
| AFMD | New | AFFIMED N V | $383,000 | – | 45,000 | +100.0% | 0.03% | – |
| RAIN | New | RAIN THERAPEUTICS INC | $282,000 | – | 18,155 | +100.0% | 0.02% | – |
| ITOS | New | ITEOS THERAPEUTICS INC | $198,000 | – | 7,700 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.